Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,338
Closed -$8.49K 3451
2025
Q3
$8.49K Hold
2,338
﹤0.01% 2473
2025
Q2
$9.82K Sell
2,338
-714
-23% -$2.8K ﹤0.01% 2359
2025
Q1
$10.2K Sell
3,052
-890
-23% -$3.64K ﹤0.01% 2347
2024
Q4
$16.4K Sell
3,942
-1,216
-24% -$5.1K ﹤0.01% 2158
2024
Q3
$18.8K Buy
5,158
+674
+15% +$2.67K ﹤0.01% 2070
2024
Q2
$21.5K Buy
4,484
+3,436
+328% +$19.3K ﹤0.01% 1935
2024
Q1
$8.21K Buy
1,048
+54
+5% +$425 ﹤0.01% 2370
2023
Q4
$11.7K Buy
994
+452
+83% +$4.43K ﹤0.01% 2192
2023
Q3
$5.35K Buy
542
+398
+276% +$4.68K ﹤0.01% 2465
2023
Q2
$1.63K Hold
144
﹤0.01% 2868
2023
Q1
$1.5K Sell
144
-206
-59% -$1.97K ﹤0.01% 2882
2022
Q4
$2.83K Sell
350
-110
-24% -$962 ﹤0.01% 2684
2022
Q3
$4K Sell
460
-1,698
-79% -$20.3K ﹤0.01% 2513
2022
Q2
$26K Buy
2,158
+1,688
+359% +$22.1K ﹤0.01% 1639
2022
Q1
$7K Buy
+470
New +$8.04K ﹤0.01% 2328

Other funds holding EVO

SignatureFD's EVO Position: Q4 2025 in Review

SignatureFD sold out of Evotec (EVO) in Q4 2025, closing a stake of 2,338 shares — an estimated $8.49K sold.

SignatureFD first reported a position in EVO in Q1 2022 and held it in 15 quarters. The position peaked at $26K in Q2 2022. 44 funds tracked by Wall St. Rank hold EVO as of Q4 2025.

  • SignatureFD reported no remaining Evotec position as of Q4 2025 after selling out during the quarter.
  • SignatureFD sold 2,338 Evotec shares in Q4 2025, an estimated $8.49K.
  • SignatureFD first reported a position in Evotec in Q1 2022 and held it in 15 quarters.
  • SignatureFD's Evotec position peaked at $26K in Q2 2022.
  • 44 funds tracked by Wall St. Rank held Evotec as of Q4 2025.

Based on SignatureFD's 13F filing for Q4 2025, filed 20 Jan 2026.